Live attenuated vaccine: the first clinically approved dengue vaccine? (Q42998710)

12 November 2017

0 references

Live attenuated vaccine: the first clinically approved dengue vaccine? (English)

1 reference

12 November 2017

0 references

1 reference

2

Pei-Yong Shi

1 reference

12 November 2017

Katja Fink

1

1 reference

12 November 2017

18 December 2013

1 reference

Expert Review of Vaccines

12 November 2017

1 reference

12 November 2017

13

1 reference

12 November 2017

2

1 reference

12 November 2017

185-188

1 reference

Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial

12 November 2017

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.870888

Plasmablasts generated during repeated dengue infection are virus glycoprotein-specific and bind to multiple virus serotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.870888

Determinants of inapparent and symptomatic dengue infection in a prospective study of primary school children in Kamphaeng Phet, Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.870888

Reduced risk of disease during postsecondary dengue virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.870888

Role of humoral versus cellular responses induced by a protective dengue vaccine candidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.870888

Differential targeting of viral components by CD4+ versus CD8+ T lymphocytes in dengue virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.870888

CD4+ T cells are not required for the induction of dengue virus-specific CD8+ T cell or antibody responses but contribute to protection after vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.870888

A Protective Role for Dengue Virus-Specific CD8+ T Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.870888

A single dose of any of four different live attenuated tetravalent dengue vaccines is safe and immunogenic in flavivirus-naive adults: a randomized, double-blind clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.870888

Development of DENVax: a chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.870888

A chimeric dengue virus vaccine using Japanese encephalitis virus vaccine strain SA14-14-2 as backbone is immunogenic and protective against either parental virus in mice and nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.870888

Rational design of a live attenuated dengue vaccine: 2'-o-methyltransferase mutants are highly attenuated and immunogenic in mice and macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.870888

Heterotypic dengue infection with live attenuated monotypic dengue virus vaccines: implications for vaccination of populations in areas where dengue is endemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.870888

Critical issues in dengue vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.870888

Genetic and phenotypic characterization of manufacturing seeds for a tetravalent dengue vaccine (DENVax).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.870888

Antibodies to Envelope Glycoprotein of Dengue Virus during the Natural Course of Infection Are Predominantly Cross-Reactive and Recognize Epitopes Containing Highly Conserved Residues at the Fusion Loop of Domain II

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.870888

Manipulation of immunodominant dengue virus E protein epitopes reduces potential antibody-dependent enhancement

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.870888

Atomic-level functional model of dengue virus Envelope protein infectivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.870888

Identifying protective dengue vaccines: guide to mastering an empirical process

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.870888

10.1586/14760584.2014.870888

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference

PubMed ID

24350687